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Itch is the least well understood of all the somatic
senses, and the neural circuits that underlie this
sensation are poorly defined. Here we show that
the atonal-related transcription factor Bhlhb5 is tran-
siently expressed in the dorsal horn of the developing
spinal cord and appears to play a role in the forma-
tion and regulation of pruritic (itch) circuits. Mice
lackingBhlhb5 develop self-inflicted skin lesions and
show significantly enhanced scratching responses
to pruritic agents. Through genetic fate-mapping
and conditional ablation, we provide evidence that
the pruritic phenotype in Bhlhb5 mutants is due to
selective loss of a subset of inhibitory interneurons
in the dorsal horn. Our findings suggest that Bhlhb5
is required for the survival of a specific population
of inhibitory interneurons that regulate pruritis, and
provide evidence that the loss of inhibitory synaptic
input results in abnormal itch.
INTRODUCTION
Both itch and pain serve crucial roles: they alert the organism to
potential harm and trigger behavioral responses that prevent
injury. However, our perceptual experience of these two sensa-
tions is qualitatively distinct, and our responses to them are very
different. Itch is a skin-specific sensation that provokes the
desire to scratch, thereby removing potentially harmful agents,
such as a parasite, from the skin’s surface. In contrast, pain886 Neuron 65, 886–898, March 25, 2010 ª2010 Elsevier Inc.can occur in any part of the body and, when it originates from
the skin, triggers withdrawal, thereby removing us from harm’s
way (Yosipovitch et al., 2007). Both pain and itch can, however,
become chronic pathological conditions (Ikoma et al., 2006).
Unfortunately, effective treatment for chronic pain or itch is lack-
ing, and progress in the development of new therapies is
hampered by insufficient knowledge of the neural circuits that
underlie these distinct sensations.
Our understanding of itch is limited, and the existence of itch-
specific circuits is controversial (reviewed in McMahon and
Koltzenburg, 1992; Schmelz, 2008). It has been hypothesized,
for example, that itch might be distinguished from pain based
simply on the pattern of firing or rate of discharge of C-fiber
primary sensory neurons because many C-fibers respond both
to algesic (pain-inducing) and pruritic (itch-inducing) compounds
(Simone et al., 2004). However, recent work has supported an
alternative theory—a so-called labeled-line for itch, in which
a specific subset of C-fibers selectively conveys the sensation
of itch from the skin to the spinal cord, where it is relayed in
a unique projection pathway to the brain. A subpopulation of
primary sensory neurons that respond selectively to the pruritic
agent histamine are present in humans (Schmelz et al., 1997),
as are second-order spinal projection neurons that respond to
histamine in the cat (Andrew and Craig, 2001). Additional
evidence that itch and pain are mediated by distinct neurons
has emerged recently with reports that gastrin-releasing peptide
receptor (GRPR)-expressing neurons in the spinal cord are
specifically responsive to pruritic stimuli (Sun and Chen, 2007),
and more compellingly, that selective ablation of these neurons
eliminates itch but not pain (Sun et al., 2009).
Despite these advances, pruritic circuitry remains poorly
understood. In particular, although itch information is integrated
Figure 1. Bhlhb5 Is Transiently Expressed in
Excitatory and Inhibitory Neurons in the
Dorsal Spinal Cord
(A) Expression of Bhlhb5 protein in the mouse
spinal cord embryonic day (E) 13.5, E16.5, and
postnatal day 0 (P0) using anti-Bhlhb5 antibodies.
The generation of Bhlhb5 antibodies used in this
study is described in Figures S1A–S1C. (B) Co-
staining of Bhlhb5 protein (red) with antibodies to
the excitatory marker Lmx1b (blue) and the inhibi-
tory marker Pax2 (green) in the dorsal horn of the
spinal cord at P0. Dotted line denotes the dorsal
horn region that was quantified in (C). (C) Quantifi-
cation of the proportion of Bhlhb5-expressing
neurons (Bhlhb5+) that colocalize with either
Lmx1b or Pax2 indicates that Bhlhb5 is expressed
in both excitatory and inhibitory neurons of
the dorsal spinal cord. Data are presented as
mean ± SEM. (n = 3 littermate pairs, counting 10
matched lumbar sections/pair).
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neurons involved in regulating itch await discovery. For instance,
it is a common experience that inducing pain (e.g., by scratching)
relieves itch (Ikoma et al., 2006). Conversely, relieving pain (e.g.,
with mu-opioids) induces itch (Umeuchi et al., 2003). The mutu-
ally antagonistic relationship between itch and pain suggests the
involvement of inhibitory circuits within the dorsal spinal cord.
However, such circuits have not been identified or characterized.
A second type of modulation that occurs in the dorsal spinal cord
is central sensitization, a type of sensory ‘‘learning’’ involving
long-lasting changes in circuit properties that increase pain
sensitivity (Woolf, 1983). This type of sensory plasticity occurs
through multiple mechanisms, including an increase in the
excitability of spinal cord neurons that mediate pain and a reduc-
tion in inhibitory synaptic input onto these cells (disinhibition)
(reviewed in Latremoliere and Woolf, 2009). While central sensi-
tization in response to itch (Ikoma et al., 2004), like that observed
in response to pain, is thought to occur primarily in the dorsal
spinal cord, the mechanisms involved are not known. Thus, there
is a fundamental gap in knowledge with regard to the most basic
spinal cord circuits that mediate pruritis.
Here we describe a mouse model involving mutation of the
transcription factor Bhlhb5 that shows dramatically heightened
responses to pruritic stimuli, enabling us to investigate the
neural circuitry that underlies itch. Bhlhb5 is a neural-specific
basic helix-loop-helix (bHLH) transcription factor related to the
Drosophila proneural factor atonal (Ross et al., 2003). Compared
to other well-studied members of this family, such as the Neu-
roD, Neurogenin, and Olig transcription factors, little is known
about the function of Bhlhb5 in the nervous system. Previous
work has identified an important role for Bhlhb5 in the retina,
where it is required for the survival of some amacrine and cone
bipolar cells (Feng et al., 2006). In addition, Bhlhb5 regulates
the acquisition of area-specific fates in the cortex (Joshi et al.,
2008). However, the function of Bhlhb5 in somatosensory
systems has not been investigated.Within the spinal cord, Bhlhb5 is transiently expressed in
subsets of postmitotic neurons, suggesting a possible role in
the assembly of spinal circuits. We investigated this idea by
generating a series of mutant mice in which the function of the
Bhlhb5 gene is disrupted. We show that animals lacking Bhlhb5
develop self-inflicted skin lesions and provide evidence that
these lesions are due to heightened itch. To understand the
molecular basis for this behavioral phenotype, we use a genetic
fate mapping strategy in which Bhlhb5-expressing cells are
permanently marked in vivo and uncover a crucial role for Bhlhb5
in the survival of a specific population of neurons in the superfi-
cial laminae of the dorsal horn. Furthermore, through conditional
ablation, we provide evidence suggesting that loss of Bhlhb5
within inhibitory neurons in the dorsal horn results in the develop-
ment of pathological skin lesions. Together, these data suggest
a model in which disinhibition in the dorsal spinal cord results in
abnormal itch.
RESULTS
Bhlhb5 Is Expressedwithin the Dorsal Horn of the Spinal
Cord andMice Lacking This FactorDevelopSkin Lesions
To gain insight into the mechanisms that regulate neuronal circuit
assembly in the spinal cord, we examined Bhlhb5 expression in
the developing spinal cord by immunohistochemistry using
several newly generated Bhlhb5-directed antibodies (Figures
S1A–S1C, available online). Bhlhb5 was observed in a subpopu-
lation of late-born neurons that migrate to the superficial layers of
the dorsal horn (Figure 1A), and was transiently expressed earlier
in the embryo in V1, V2, and dI6 interneurons (Figures S1D and
S1E), consistent with previous reports (Liu et al., 2007). Colocal-
ization studies using glutamatergic and GABAergic neuronal
markers (Lmx1b and Pax2, respectively) (Cheng et al., 2005),
revealed that approximately one-third of Bhlhb5-expressing
neurons in the dorsal horn are excitatory, and two-thirds, inhibi-
tory (Figures 1B and 1C). Expression of Bhlhb5 in the dorsal hornNeuron 65, 886–898, March 25, 2010 ª2010 Elsevier Inc. 887
Figure 2. Loss of Bhlhb5 Gives Rise to Mice that
Develop Self-Inflicted Skin Lesions due to Exces-
sive Licking and Scratching
(A) Schematic illustrating the Bhlhb5 knockout allele in
which the Bhlhb5 gene is replaced by a neomycin expres-
sion cassette. Arrow indicates transcriptional start site.
Also see Figure S2.
(B) Photos illustrating the skin lesions on Bhlhb5 knockout
mice.
(C) Behavioral analysis of wild-type (+/+), heterozygous
(+/), or Bhlhb5 null (/) mice with pre-existing skin
lesions showing proportion of time spent at each activity
over a 20 min period indicates that Bhlhb5/ mice spend
the majority of their time licking and scratching at the site
of lesion, whereas wild-type and heterozygous mice divide
their time between normal head-to-toe grooming (groom-
ing chain), exploring/ambulating, or resting (stationary).
Note that, prior to the onset of skin lesions, Bhlhb5/
mice do not display abnormal scratching or licking
behavior. However, once a very small skin irritation
develops, Bhlhb5/ mice lick and scratch persistently
such that a skin lesion develops very soon thereafter.
(D) Time course of skin lesion onset reveals that the
majority of Bhlhb5 mutants develop skin lesions between
4 and 8 weeks. Also see Figures S3A and S3D.
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mitosis (E13.5) and persisting for up to 2 weeks postnatally.
This extended expression of Bhlhb5 suggests a possible role
for Bhlhb5 in the later aspects of neuronal differentiation, such
as circuit assembly.
To investigate the function of Bhlhb5 in the developing spinal
cord, we generated a Bhlhb5 knockout mouse (Figures 2A and
S2). Constitutive loss of Bhlhb5 gave rise to mice that appeared
to have severe somatosensory defects, as evidenced by self-
inflicted skin lesions (Figure 2B). We observed these mice care-
fully and found that the skin lesions were due to excessive
licking and scratching (Figure 2C). By 4 weeks of age, one-third
of Bhlhb5 mutants had developed skin lesions, and at 8 weeks
of age, skin lesions were observed in almost every Bhlhb5
knockout mouse (Figure 2D), irrespective of genetic background
(129/Sv, C57Bl/6, and CD1). The skin lesions were frequently
found on the perineum and the haunches (Figure S3A), but occa-
sionally observed in many other regions, such as orafacial area.
In contrast, skin lesions were never observed in wild-type or
heterozygous mice.
We analyzed the epidermis of Bhlhb5 knockout mice prior to
the development of skin lesions but found that there was no
evidence of abnormal innervation, as revealed by PGP9.5 stain-
ing (Figures S3B and S3C). Furthermore, electron micrographs
of dorsal roots showed no evidence of neuropathy in Bhlhb5
mutants (Figure S3D).
Bhlhb5/ Mice Show Heightened Responses
to Itch-Inducing Agents
Based on the skin lesions and the scratching behavior observed
in Bhlhb5/ mice, we hypothesized that these mice might be
responding to an itch-like sensation. To test itch responsiveness,
we examined the scratching behavior of mice that had received
intradermal injections of pruritic agents into the nape of the neck.
Because the presence of skin lesions was found to be a888 Neuron 65, 886–898, March 25, 2010 ª2010 Elsevier Inc.potentially confounding factor in the behavioral assays (Figures
S3F–S3H), these experiments were performed using young
(4-week-old) Bhlhb5 mutant mice, prior to the onset of skin
lesions. Although the signaling events that initiate itch in the
skin are not well understood, they occur through at least two
independent pathways (Davidson et al., 2007). One mechanism
is mediated by histamine receptors, which can be activated
by histamine itself or by compound 48/80, a chemical that
mediates histamine release from mast cells (Kuraishi et al.,
1995). The second mechanism is mediated by Protease-acti-
vated receptor2 (PAR2), which can be activated by peptide
agonists such as SLIGRL-NH2 (Reddy et al., 2008). Bhlhb5
mutants showed elevated itch responses upon activation of
either histamine-dependent or PAR2-dependent mechanisms
(Figure 3A). Thus, multiple pruritogens, acting through at least
two distinct mechanisms, give rise to significantly elevated
itch responses in Bhlhb5 mutant mice. In addition, we tested
a-methyl-5-hydroxytryptamine (aMe5HT), a serotonin analog
that causes inflammation and pruritis when administered periph-
erally (Yamaguchi et al., 1999); chloroquine, an antimalarial drug
that causes itch (as a side effect) through direct activation of
sensory neurons (Sowunmi et al., 1989; Liu et al., 2009); and
formalin, a pain-inducing chemical that has been found to elicit
scratching when injected intradermally (Imamachi et al., 2009).
Regardless of the pruritic agent used, Bhlhb5/ mice showed
significantly more scratching behavior than wild-type mice
(Figure 3A).
The excessive scratching response observed in the Bhlhb5/
mice was consistent with the possibility that the skin lesions that
occur in these mice might be due to a heightened sensation of
itch. In support of this hypothesis, we found that the presence
of skin lesions is associated with elevated neuronal activity in
the dorsal horn, a region of the nervous system in which pruritic
information is thought to be integrated. Specifically, c-Fos was
upregulated in the dorsal spinal cord of Bhlhb5 mutants with
Figure 3. Bhlhb5/ Mice Have Elevated Itch Responses
(A) Bhlhb5/ mice show significantly enhanced scratching responses
following the intradermal injection of pruritic agents into the nape of the
neck. Agents tested were histamine, a serotonin analog (aMe-5HT), a PAR2
agonist (SLIGRL-NH2), compound 48/80 (48/80), formalin, and chloroquine
(CQ). Experiments were performed with four or five littermate pairs that were
3 to 4 weeks old, prior to the development of skin lesions in Bhlhb5/ mice.
Data are presented as mean ± SEM, and (*) indicates significant difference
relative to controls (p < 0.05, t test).
(B) Abnormal expression of c-Fos in the dorsal horn corresponds to the site of
skin lesions in Bhlhb5/ mice. Immunostaining with anti-c-Fos antibodies
reveals elevated c-Fos expression in a segment of the dorsal horn that corre-
sponds to the sites of a skin lesion (S1), but not in a matched segment from
a Bhlhb5/ mouse that lacks lesions.
(C) Local injection of lidocaine causes the abnormal scratching and licking
behavior to attenuate in Bhlhb5/ mice. Bhlhb5/ mice with lesions of the
perineum were used. All mice received an injection of either PBS (control) or
lidocaine (to block sensory input) into the perineum. Injection of lidocaine in
wild-type mice had no effect on licking and scratching behavior. Data are pre-
sented as mean ± SEM. and (*) indicates significant difference relative to treat-
ment with vehicle (p < 0.05, t test).
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(Figure 3B). Moreover, c-Fos expression was observed in
segments of the dorsal horn of spinal cord that correspond to
the site of lesions, and not in other levels of the spinal cord
(data not shown). Next, we reasoned that if Bhlhb5/ mutant
mice with skin lesions were compelled to scratch by a sensation
of itch, then they would cease scratching if itch sensation were
blocked. To test this idea, we used lidocaine to block sensory
input from primary sensory neurons (Holstege et al., 2008). Strik-
ingly, we found that loss of sensory input through the use of lido-
caine completely attenuated the licking/scratching behavior
directed toward the lesioned area (Figure 3C). Based on this
finding, together with the observation that Bhlhb5 mutants
respond excessively to itch-inducing stimuli, we theorize that
the skin lesions are caused by a site-specific itch that leads to
the abnormal scratching and/or licking behaviors. Although we
cannot know with certainty how these mice are feeling, theirscratching behavior is suggestive of itch. For simplicity, we refer
hereafter to the sensation that is driving the scratching behavior
as itch.
Bhlhb5/ Mice Have Similar Acute Nociceptive
Responses but Show Evidence of Enhanced Central
Sensitization
Next we investigated whether the Bhlhb5/ mice also respond
abnormally to other somatosensory modalities such as touch
and pain. Upon stimulation with von Frey filaments to measure
mechanical sensitivity, wild-type and Bhlhb5/ mice showed
similar paw-withdrawal thresholds (Figure 4A). When placed on
a hot plate, wild-type and Bhlhb5/ mice responded with a
similar latency, indicating that thermal sensitivity is unchanged
in Bhlhb5 mutants (Figure 4B). Similarly, wild-type and Bhlhb5
mutant animals showed no significant differences in the duration
of their paw-licking behavior upon the intraplantar injection of
capsaicin or mustard oil, a TRPV1 and TRPA1 agonist, respec-
tively, indicating that loss of Bhlhb5 does not affect nociceptive
responses to chemical algesics (Figures 4C and 4D). Finally, in
assays for inflammation-induced mechanical hypersensitivity,
no significant differences were observed between genotypes;
both wild-type and Bhlhb5 mutant littermates showed similar
levels of heightened sensitivity following the intraplantar injection
of carrageenan, suggesting that mechanical allodynia is also
unaffected by the loss of Bhlhb5 (Figure 4E). Together, these
results suggest that the responses to various types of noxious
sensory stimuli—mechanical, thermal, and chemical—are not
significantly different between wild-type and Bhlhb5 mutants,
at least in young (4-week-old) mice.
While Bhlhb5 mutant mice showed no significant changes
in their responses to most nociceptive sensory assays, the
formalin test was a marked exception. In this paradigm, a
biphasic behavioral response (primarily licking of the hindpaw)
is seen in response to the intraplantar injection of 5% formalin.
The immediate, early-phase response is due to acute activation
of TRPA1-expressing primary nociceptors (McNamara et al.,
2007), whereas the late-phase response is believed to be due
to activity-dependent central sensitization (Tjølsen et al., 1992)
and ongoing afferent input (Puig and Sorkin, 1996). Using this
test we found that, although the response observed in the early
phase was similar between genotypes, the response observed
during the late phase was significantly different. Specifically,
the licking behavior during the second phase of the formalin
test was almost 4-fold greater in Bhlhb5 mutants than in wild-
type littermates (Figure 4F).
Formalin is a reactive chemical that activates TRPA1
(McNamara et al., 2007), causing widespread tissue damage
and inducing pain in animals and man (Dubuisson and Dennis,
1977). Many inflammatory mediators are released in response
to formalin at doses used in the standard test, including ATP
and H+ from leaking membranes, histamine from degranulated
mast cells, and peptide agonists from activated proteases
(Tjølsen et al., 1992). Thus, we hypothesized that, in addition to
activating nociceptors, formalin treatment may also cause the
release of agents that activate pruritoceptors. Consistent with
this, formalin elicits primarily a scratching response rather than
a wiping response when injected intradermally into the cheekNeuron 65, 886–898, March 25, 2010 ª2010 Elsevier Inc. 889
Figure 4. Bhlhb5/ Mice Show Evidence of Enhanced Central
Sensitization
(A) Mechanical sensitivity as assessed by measuring the withdrawal threshold
upon application of von Frey fibers to the plantar surface of the hindpaw.
(B) Thermal sensitivity as assessed by measuring the response latency when
placed on a 55C hot plate.
(C and D) Acute nociception as assessed by measuring the duration of licking
following the injection of capsaicin (C) or mustard oil (D) into the hindpaw.
(E) Mechanical hypersensitivity as assessed by measuring the withdrawal
threshold prior to and 2 hr following the injection of carrageenan into the
hindpaw.
(F) Upon injection of 5% formalin into the hindpaw, wild-type (WT) and
Bhlhb5/ mice show a similar response in the early phase (0–20 min); how-
ever, during the late phase (20–40 min), Bhlhb5/ mice spend significantly
Neuron
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890 Neuron 65, 886–898, March 25, 2010 ª2010 Elsevier Inc.(Figure S3E). This behavioral assay is thought to distinguish
between pain and itch, because the noxious irritant capsaicin
elicits wiping by the forepaw whereas the pruritogen histamine
evokes scratching by the hindpaw (Shimada and LaMotte,
2008). Thus, the finding that formalin induces scratching in
this assay suggests that formalin may elicit itch in addition to
pain. If so, the heightened response to formalin observed in
Bhlhb5/ mice might reflect, at least in part, an abnormal itch
sensation. Alternatively, it is possible that the Bhlhb5/ pheno-
type may include a pain component, but if so, it appears to be
restricted to formalin, and not heat, capsaicin, mustard oil, or
carrageenan.
Conditional Ablation Points to a Possible Role
for the Dorsal Horn of the Spinal Cord in the Abnormal
Itch of Bhlhb5/ Mice
Since itch circuits are poorly characterized but are thought to
involve numerous regions of the nervous system, we used condi-
tional ablation to help identify the neurons whose dysfunction
causes excessive itch inBhlhb5mutants. Specifically, we gener-
ated a Bhlhb5 allele that was flanked by loxP sites (Figures 5A
and S4) and crossed it to a variety of cre-expressing mouse lines
in which cre-mediated recombination occurs within discrete
regions of the nervous system. The selective disruption of
Bhlhb5 in neuronal precursors by crossing the conditional
Bhlhb5 knockout to a Nestin-cre line (Tronche et al., 1999)
gave rise to mice with skin lesions, suggesting that the scratch-
ing behavior in the Bhlhb5/ mice is neural in origin (Figure 5B)
and excluding the possibility that the self-injurious grooming
behavior in the mutant mice was due to topical dermatitis. One
of the regions of the nervous system in which Bhlhb5 is highly
expressed is in the dorsal telencephalon (Joshi et al., 2008).
However, loss of Bhlhb5 in the dorsal telencephalon using the
Emx-cre line (Gorski et al., 2003) was not sufficient for the devel-
opment of skin lesions (Figure 5B), suggesting that higher
cortical function was not involved in this phenotype. In contrast,
the loss of Bhlhb5 resulting from Wnt1-driven cre expression
(Rico et al., 2002) was found to be sufficient for the development
of skin lesions (Figure 5B), and the incidence of these lesions was
identical in frequency, location, and severity to those observed in
theBhlhb5 knockout mouse (data not shown). Analysis of Bhlhb5
protein expression following Wnt1-cre-mediated recombination
confirmed that Bhlhb5 was selectively lost from the dorsal, but
not the ventral, horn of the spinal cord, as expected based on
the distribution of Wnt1-cre-mediated reporter expression
(Figure 5C). In addition, Wnt1-cre;Bhlhb5fl/fl mice showed signif-
icantly elevated scratching responses in response to the pruritic
agent compound 48/80 (Figure 5D). Together these data indicatemore time licking their hindpaws, suggestive of enhanced central sensitization
in these mice. Data are presented as mean ± SEM, and (*) indicates a significant
difference relative to controls at the same time point (p < 0.05, Mann-Whitney
U-test). These experiments were performed with six to eight littermate pairs
that were 4 weeks old, prior to the development of skin lesions in Bhlhb5/
mice. (When older mice were used in these studies, Bhlhb5/ mice were
found to have reduced responses in all behavioral assays, possibly due to
the presence of skin lesions on these mice, which may have been a confound-
ing factor; Figures S3E–S3G).
Figure 5. Conditional Ablation Points to a Possible Role of the Dorsal Horn in the Abnormal Itch in Bhlhb5 Mutant Mice
(A) Schematic illustrating the conditional Bhlhb5 knockout allele in which the Bhlhb5 gene is floxed by loxP sites (<), enabling cre-mediated recombination.
Arrow indicates transcriptional start site. Also see Figure S4.
(B) Table listing the cre-expressing mouse lines used to cause selective ablation ofBhlhb5, together with the expression pattern of cre in each line and whether the
subsequent animals develop skin lesions following cre-mediated recombination of Bhlhb5. 1Wnt1-cre also causes recombination in the cerebellum and other
neural crest-derived cells in addition to dorsal root ganglia (DRG) neurons. 2HtPa-cre causes recombination in other neural crest-derived cells in addition to
DRG neurons. Also see Figure S5. The expression pattern of each cre line was confirmed using cre-responsive reporter mice (data not shown).
(C) Wnt1-cre-mediated loss of Bhlhb5. Lumbar sections from P0 animals stained with antibodies for Bhlhb5 (red) and eYFP (green). Sections from control (left)
and mutant mouse (right) are homozygous floxed at the Bhlhb5 locus (Bhlhb5fl/fl). In addition, the mutant mouse harbors the Wnt1-cre allele and the Rosa26 cre-
responsive eYFP reporter (eYFP reporter). Insets are enlarged on right. eYFP staining reveals cells in which cre-mediated recombination has occurred. Note that
Bhlhb5 staining is absent from the dorsal horn of mutants, but not the ventral horn.
(D) Conditional loss ofBhlhb5 in theWnt1-cre expression domain results in significantly elevated scratching responses following the injection of compound 48/80
intradermally into the nape of the neck relative to homozygous floxed control mice. Data are presented as mean ± SEM, and (*) indicates significant difference
relative to controls (p < 0.05, t test). Though conditional loss of Bhlhb5 pointed to a possible role of the dorsal horn in the abnormal itch, no gross defects in the
dorsal spinal cord were observed in Bhlhb5 mutant mice (Figure S6).
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responsible for the development of abnormal itch.
Although Wnt1-mediated cre expression causes recombina-
tion in several regions in the nervous system (see Figure 5B),
there were two regions in particular known to mediate pruritis:
the dorsal root ganglia (DRG), which contains primary prurito-
ceptive neurons that initiate itch, and the dorsal horn of the spinal
cord, which contains interneurons and projection neurons that
integrate pruritic information and relay it to the brain (Sun et al.,
2009). To help distinguish which of these two regions might be
responsible for the self-injurious behavior in Bhlhb5 mutant
mice, we used the HtPa-cre line, which results in the loss of
Bhlhb5 in all neural-crest-derived cells (including all DRG
neurons), but not in neurons of the spinal cord (Figure S5; Pietri
et al., 2003).HtPa-cre-mediated ablation ofBhlhb5was not suffi-
cient, however, for the development of skin lesions (Figure 5B).Together, these findings suggest that the loss of Bhlhb5 within
the dorsal horn is necessary for heightened itch inBhlhb5mutant
mice.
A Subpopulation of Bhlhb5-Expressing Neurons Is
Absent from the Superficial Dorsal Horn of Bhlhb5
Mutant Mice
While the conditional ablation studies raised the possibility that
defects within the dorsal horn of the spinal cord lead to abnormal
itch in Bhlhb5 mutant mice, the cellular basis for this phenotype
was unknown. Mice lacking Bhlhb5 were found to have no
obvious or major disruption of dorsal horn anatomy based on
expression of a variety of spinal cord neuronal markers, including
PKCg, calbindin, calretinin, Substance P, IB4, and CGRP (Fig-
ure S6). Recent reports have suggested that DRG neurons
that express gastrin-related peptide (GRP) are specific for itchNeuron 65, 886–898, March 25, 2010 ª2010 Elsevier Inc. 891
Figure 6. A Subpopulation of Bhlhb5-Expressing Neurons Is Absent
from the Superficial Dorsal Horn of Bhlhb5 Mutant Mice
(A) Schematic illustrating the Bhlhb5-cre knockin allele in which the coding
region of the Bhlhb5 gene was replaced with the coding region of the cre
recombinase gene. Also see Figure S7.
(B) Diagram illustrating the mechanism whereby the Bhlhb5-cre allele causes
irreversible recombination of the Rosa26 reporter, resulting in the removal of
a stop signal and expression of the reporter (bgalactosidase or eYFP).
(C)Specificityof theBhlhb5-creallele. Representative regionofdorsal spinalcord
fromP0mice that are heterozygous for theBhlhb5-crealleleandharbor the Rosa-
eYFP reporter were stained with antibodies to Bhlhb5 (red) and eYFP (green).
Note that at this time point, almost all labeled cells are double-labeled (yellow),
indicating cre-mediated recombination has occurred in Bhlhb5-expressing cells.
(D) Bhlhb5-cre knockin reveals the fate of Bhlhb5-cre-marked cells in the
spinal cord of control (Bhlhb5-cre/+) and mutant (Bhlhb5-cre/) mice. Cre-
responsive Rosa26-LacZ reporter is used to mark cells in which Bhlhb5-cre
was expressed. Sections are from representative lumbar spinal cord hemisec-
tions from P28 mice. Dorsal horn is enlarged in inset for control (i) and mutant
(ii) mice. Arrows indicate region of cell loss in mutant mice. Quantification
reveals an 50% loss of lacZ-expressing cells in the superficial dorsal horn
of the spinal cord (data not shown, n = 4 pairs of mice, counting 20 matched
lumber sections/pair). See also Figure S8A. Note that no sensory phenotypes
are observed in control mice that are heterozygous for Bhlhb5, and the dorsal
horn appears grossly normal based on the analysis of a number of other neural
markers (Figure S6).
Neuron
Disinhibition in the Dorsal Horn and Itch
892 Neuron 65, 886–898, March 25, 2010 ª2010 Elsevier Inc.(Sun and Chen, 2007). However, when we looked specifically at
this population, we found that the number of GRP-expressing
neurons in the DRG was unchanged in Bhlhb5 mutants (data
not shown), and the innervation by GRP-expressing neurons in
the dorsal horn appeared unaffected by the loss of Bhlhb5
(Figures S6G and S6H).
The absence of an easily discernable defect in the dorsal
spinal cord of Bhlhb5 mutants was not altogether unexpected
given that Bhlhb5 is expressed in just a small subset of those
neurons. To determine whether there is a subtle defect in itch
circuitry within the dorsal spinal cord, we needed an approach
to selectively define the cells that express Bhlhb5 and observe
the subsequent fate of these cells in mice lacking Bhlhb5.
Toward this end, we generated a Bhlhb5-cre knockin animal
(Bhlhb5-cre), in which the coding region of the Bhlhb5 gene
was replaced with cre recombinase (Figures 6A and S7). Upon
crossing this Bhlhb5-cre line with a cre-responsive reporter
line, cells in which the Bhlhb5 gene has been activated become
permanently marked with the reporter (Figure 6B), allowing the
fate of Bhlhb5-expressing cells to be resolved at a cellular level
and followed throughout the life of the animal.
For these experiments, we used three different cre-responsive
indicator alleles (Rosa26-lacZ, Rosa26-eYFP, or Z/EG reporters)
(Soriano, 1999) to visualize genetically marked neurons. For
simplicity, we refer to these neurons as B5-cre-lacZ, B5-cre-
eYPF, or B5-cre-Z/EG marked neurons, respectively. Analysis
of reporter expression in newborn mice that are heterozygous
for the Bhlhb5-cre allele revealed that B5-cre-eYFP and Bhlhb5
were almost completely colocalized, indicating that reporter
expression faithfully recapitulated the endogenous expression
pattern of Bhlhb5 (Figure 6C).
Upon crossing the Bhlhb5-cre line with the Rosa26-lacZ
reporter, we found that lacZ marked a small subset of neurons
throughout all laminae of the spinal cord in adult mice (Fig-
ure 6D). In mice lacking Bhlhb5, most regions of the spinal
cord showed a similar pattern of B5-cre-lacZ cells. However,
specifically in the superficial laminae, we found significantly
fewer B5-cre-lacZ neurons in the Bhlhb5 mutants (Figure 6D).
Quantification revealed that approximately 50% of neurons
that would normally have expressed Bhlhb5 were missing in
the superficial dorsal horn of adult mice lacking Bhlhb5. Further-
more, this cell loss was observed throughout the rostro-caudal
axis of the spinal cord (data not shown). To verify this finding
and to rule out potential effects specific to the Rosa locus, we
used the Z/EG line as a reporter and we again observed signifi-
cant loss of cell bodies and neuropil in Bhlhb5 mutants relative
to control animals (Figure S8A). Coimmunostaining with CGRP(E) Coimmunostaining with antibodies against Prdm8 (red) and Bhlhb5 (blue)
reveal that these two factors show a very high degree of colocalization (merge;
purple) in the dorsal horn of mice at P0, suggesting that Prdm8 is a marker for
Bhlhb5-expressing cells.
(F) Representative lumbar sections from P0 mice stained with antibodies to
Prdm8 reveal that there is a loss of Prdm8-expressing neurons in Bhlhb5
mutants relative to controls.
(G) Quantification of Prdm8-positive (+ve) cells in the superficial dorsal horn of
control (Con) and Bhlhb5 mutant (Mut) mice. (n = 3 pairs of mice, counting 10
matched lumber sections/pair). Data are presented as mean ± SEM. *p < 0.05,
t test.
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inner lamina II) revealed a decrease in the number of B5-cre-
Z/EG marked cells within the superficial layers in mutant mice.
Given that the decrease in genetically labeled cells is observed
using cre reporters that are expressed from different promoters
and distinct loci, it is unlikely that these effects are due to misre-
gulation of the reporter alleles.
While a loss of Bhlhb5 neurons seemed the most likely expla-
nation for these findings, it remained possible that the reduction
in the number of Bhlhb5-cre-labeled neurons in the Bhlhb5
mutant reflected merely misregulation of the Bhlhb5-cre allele.
To address this possibility, we searched for another marker of
Bhlhb5-expressing cells with which to confirm our findings.
Our studies in other regions of the nervous system (to be
described elsewhere) revealed that Bhlhb5 was largely coex-
pressed with Prdm8, a putative zinc-finger-containing transcrip-
tion factor. To assess whether Prdm8 could be used as a marker
for Bhlhb5-expressing cells in the spinal cord, we performed
double-immunolabeling experiments and found that Bhlhb5
and Prdm8 showed approximately 85% colocalization (Fig-
ure 6E). Next, we examined the number of Prdm8-expressing
cells in the dorsal spinal cord of Bhlhb5 mutant mice and found
that they were reduced by approximately 50% (Figures 6F and
6G), corroborating that a subpopulation of Bhlhb5-expressing
neurons is absent from the superficial dorsal spinal cord in
Bhlhb5 mutant mice.
Cell Loss in Bhlhb5 Mutant Mice Reflects an Increase
in Programmed Cell Death
There are several possible explanations for the decrease in
Bhlhb5-cre-marked neurons in the superficial lamina of the
dorsal horn in Bhlhb5-cre/ mice relative to Bhlhb5-cre/+
mice. The neurons might never have been born, they might
have migrated to the wrong lamina, or they might have died
during development.
Given that Bhlhb5 is expressed exclusively in postmitotic
neurons (data not shown and Liu et al., 2007), it seemed unlikely
that a loss of this factor would affect mitosis. However, to rule
out this possibility, we compared control mice (Bhlhb5-cre/+;
Rosa26-eYFP) to Bhlhb5 mutant mice (Bhlhb5-cre/; Rosa26-
eYFP), analyzing the numbers of neurons that were colabeled
with BrdU, to label dividing neurons, and eYFP, to label neurons
that were genetically marked by the Bhlhb5-cre allele. Neurons
were labeled with BrdU at either E12.5 or E13.5, the time during
which superficial dorsal horn neurons are born, and analyzed at
E17.5, after they have migrated into superficial laminae (Mizugu-
chi et al., 2006; Wildner et al., 2006). These experiments revealed
no difference in the number of genetically marked neurons that
were BrdU-positive between control and Bhlhb5 mutant mice,
indicating that loss of Bhlhb5 has no effect on the number of
dorsal horn neurons that are born (data not shown).
We next investigated the possibility that the decrease in the
number of neurons in the superficial dorsal spinal cord of Bhlhb5
mutant mice was due to a defect in migration. Toward this end,
we quantified the number of cells that express B5-cre-eYFP in
control and Bhlhb5 mutant animals at P0. This analysis revealed
that there was an 50% decrease in the number of B5-cre-
eYFP-marked neurons in the superficial dorsal horn of Bhlhb5mutants, but that no difference existed in the number of
B5-cre-eYFP-marked neurons in any other region of the spinal
cord in control and mutant mice (Figures 7A–7D). The observed
decrease in the number of B5-cre-eYFP-marked neurons in
the superficial dorsal horn of the Bhlhb5 mutant mice, without
a corresponding increase in other regions of the spinal cord,
suggests that neurons that are absent from the superficial dorsal
horn have not migrated to another region of the spinal cord.
Finally, we investigated the possibility that Bhlhb5-cre-marked
neurons might be lost in Bhlhb5 mutant mice through pro-
grammed cell death. To address this, we counted the number
of neurons that express activated caspase-3, a marker of
apoptosis (Cryns and Yuan, 1998), and found that there was
a small but significant increase in the number of apoptotic cells
in the superficial dorsal horn of Bhlhb5 mutant mice relative to
controls at E18.5, with no significant difference at E17.5 or
E19.5 (Figure 7E). The timing of this cell death was in agreement
with the observation that Bhlhb5 mutants display a clear loss of
Bhlhb5-cre-marked cells at P0 (Figure 7C), but not at (or prior to)
E17.5 (data not shown). These findings indicate that the loss of
Bhlhb5-cre-labeled cells in Bhlhb5 mutants is likely due to
apoptosis during development, and suggest that Bhlhb5 is
required for the survival of neurons in spinal cord pruritic circuits.
Inhibitory Neurons Underlie Abnormal Itch
in Bhlhb5/ Mice
To investigate whether excitatory or inhibitory neurons are lost
upon ablation of Bhlhb5, we double-labeled the B5-cre-eYFP
neurons with antibodies for excitatory (Lmx1b) or inhibitory
(Pax2) neurons (Cheng et al., 2005) and found a partial loss
of both glutamatergic and GABAergic neurons (Figure S8B).
To ascertain which subset is involved in the pruritic phenotype
in Bhlhb5 mutant mice, we used two additional cre lines, Tlx3-
cre and Pax2-cre (Ohyama and Groves, 2004; Xu et al., 2008).
Tlx3-cre causes recombination within regions of the nervous
system that include excitatory neurons within the dorsal horn
(Figures 8A and 8C), whereas Pax2-cre causes recombination
within regions of the nervous system that include most inhibitory
neurons throughout the spinal cord (Figures 8B and 8C). To
confirm that these alleles were behaving as expected, double-
labeling with markers for glutamatergic (Lmx1b-expressing)
and GABAergic (Pax2-expressing) neurons was performed.
These experiments revealed that, upon Tlx3-cre-mediated
recombination, Bhlhb5 was no longer expressed in excitatory
neurons in the dorsal horn, though it remained expressed in inhib-
itory neurons in this region (Figure 8C). Conversely, upon Pax2-
cre-mediated recombination, Bhlhb5 was no longer expressed
in inhibitory neurons, though it remained expressed in excitatory
neurons of the spinal cord (Figure 8C). Mice lackingBhlhb5 selec-
tively in glutamatergic neurons within the dorsal horn neither
developed skin lesions nor showed heightened itch responses
(Figures 8D and 8E), suggesting that Bhlhb5 function within excit-
atory neurons is not required for the pruritic phenotype. However,
use of the Pax2-cre line to ablate Bhlhb5 gave rise to mice that
both developed skin lesions and showed heightened responses
to pruritic agents (Figures 8D and 8E). These findings suggest
that the loss of Bhlhb5 in inhibitory neurons is sufficient to
produce persistent abnormal itch (Figure 8F).Neuron 65, 886–898, March 25, 2010 ª2010 Elsevier Inc. 893
Figure 7. Cell Loss inBhlhb5Mutant Mice Reflects
an Increase in Programmed Cell Death
(A) Schematic illustrating regions within a hemi-spinal cord
(dorsal horn, mid zone and ventral horn) that were used for
quantification.
(B–D) Quantification of Bhlhb5-cre-marked cells in the
lumbar spinal cord of control (Bhlhb5-cre/+) and mutant
(Bhlhb5-cre/) mice, visualized with the cre-responsive
Rosa26-eYFP reporter at P0. (B) The number of Bhlhb5-
cre-marked cells observed in various regions of a spinal
cord hemisection was quantified. Significantly fewer
Bhlhb5-cre-marked cells were found in the dorsal horn
of Bhlhb5 mutants relative to controls. No significant
changes were observed in other regions of the spinal
cord. (C) Representative images from the dorsal horn of
control and mutant mice showing Bhlhlb5-cre-marked
cells. The dorsal horn was further subdivided into regions
based on anti-calretinin antibody staining (which marks
region B; data not shown). Note that Rexed’s laminae
are not fully formed at this stage and most lamina-specific
markers are not expressed. Nevertheless, region A corre-
sponds roughly to future lamina I and region B to future
lamina II. (D) Quantification ofBhlhb5-cre-marked neurons
in regions A, B, and C, as defined above. There is a signif-
icant reduction in the number of Bhlhb5-cre marked
neurons within regions A and B of the dorsal horn in
mutants relative to controls. No significant change was
observed within region C.
(E) Analysis of apoptotic cells in the dorsal horn of control
and mutant animals at E17.5, E18.5, and E19.5, as
indicated. Apoptotic neurons in the dorsal horn were iden-
tified using an antibody against cleaved caspase-3. Sig-
nificantly more cleaved caspase-3-positive cells were
observed in the mutant dorsal horn at E18.5 relative to
littermate controls. Further analysis reveals that the
absence of Bhlhb5-expressing neurons in the dorsal
horn is due to the loss of both inhibitory and excitatory
neurons (Figure S8B).
For (B), (D), and (E), three to five pairs of littermates were
analyzed, and data represent mean ± SEM (*p < 0.05,
Mann-Whitney U-test).
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horn causes the pruritic phenotype, we analyzed c-Fos expres-
sion (as a marker of neuronal activation) following the injection
of the pruritic agent, compound 48/80, or formalin. Using this
approach, we found significantly more c-Fos-expressing cells in
the dorsal horn of Bhlhb5 mutant mice, relative to controls (Fig-
ures S8C–S8F), consistent with the idea that neurons of the dorsal
horn process information aberrantly in Bhlhb5 mutant mice.DISCUSSION
We have generated a mouse model that develops self-inflicted
skin lesions and we provide evidence that this is due to abnormal
itch responsiveness. Using a genetic fate mapping strategy, we
provide insight into the cellular basis for this phenotype, showing
that Bhlhb5 is required for the survival of a select group of
neurons within the dorsal horn. Furthermore, through conditional
ablation, we provide evidence that the loss of Bhlhb5 within
inhibitory interneurons produces the abnormal scratching
behavior that gives rise to pathological lesions.894 Neuron 65, 886–898, March 25, 2010 ª2010 Elsevier Inc.The expression of Bhlhb5 within the dorsal horn is restricted to
approximately 5% of neurons, yet its loss in the dorsal horn is
very likely responsible for the abnormal itch response we detect
in Bhlhb5 mutant mice. We have identified a specific population
of inhibitory neurons in the most superficial laminae of the
spinal cord that require Bhlhb5 for survival and appear to be
critical for regulating the normal manifestation of itch. In addition,
we provide evidence that the loss of inhibitory neurons in the
dorsal horn can give rise to persistent itch through a mechanism
of disinhibition—decreased inhibitory synaptic input in lamina I
and II of the dorsal spinal cord (Figure 8F). Thus, our data sug-
gest that itch behavior is the result of both a peripheral activation
of primary afferent pruritoceptors and central modulatory
circuits. When pruritic circuits in the dorsal horn are disinhibited,
as is seen inBhlhb5mutant mice, the activation of pruritoceptors
causes persistent itch, resulting in pathological lesions.
Bhlhb5/ mice show a dramatically elevated response in the
late phase of the formalin test, a finding widely thought to be due,
at least in part, to enhanced central sensitization (Tjølsen et al.,
1992). This type of plasticity, which occurs for both itch and
pain, heightens aversive sensation through long-term changes
Figure 8. Abnormal Itch in Bhlhb5Mutant Mice May Be Due to Loss
of Bhlhb5 from Inhibitory Neurons of the Dorsal Horn
(A and B) Loss of Bhlhb5 upon either Tlx3-cre (A) or Pax2-cre (B)-mediated
excision in conditional Bhlhb5 mutant mice (Bhlhb5fl/fl). Lumbar hemisection
from P0 mouse stained with antibodies that recognize Bhlhb5 (red) or eYFP
(green) is shown.
(C) Specificity of the Tlx3-cre and Pax2-cre alleles. Representative region of
dorsal spinal cord from P0 mice of the indicated genotypes that are stained
with antibodies that recognize Bhlhb5 (red), Lmx1b (blue), or Pax2 (green) is
shown. In control animals, Bhlhb5 colocalizes with both Lmx1b and Pax2,
as indicated by the arrows. Upon Tlx3-cre-mediated excision within excitatory
neurons, Bhlhb5 remains colocalized with the excitatory marker Pax2, but not
the inhibitory marker Lmx1b. Conversely, upon Pax2-cre-mediated excision
within inhibitory neurons, Bhlhb5 remains colocalized with the excitatory
marker Lmx1b, but not the inhibitory marker Pax2.
(D) Table describing the Tlx3-cre and Pax2-cre mouse lines, together with the
expression pattern of cre within the spinal cord for each line, and whether the
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2009; Woolf, 1983). We speculate that the abnormal itch
observed in Bhlhb5 mutant mice may be due to an enhanced
central sensitization in response to activation of itch circuits
that arises from a loss of inhibitory input in lamina I and II of
the dorsal spinal cord. Thus, it is possible that normal everyday
scratching might, in mutant mice with this form of aberrant
central sensitization, lead to the development of a pathological
itch-scratch-itch cycle. If so, this may explain why Bhlhb5/
mice develop lesions in discrete areas, despite the fact that
these mice have a loss of Bhlhb5-expressing neurons through-
out the entire rostro-caudal axis of the dorsal horn.
The finding that local anesthetic applied to the site of lesion
attenuates the scratching behavior in Bhlhb5 mutant mice
(Figure 4D) strongly suggests that activity in primary sensory
neurons is involved in the itch response. However, the itch
phenotype in Bhlhb5 mutant mice is clearly not caused by
this peripheral activity alone, since HtPa-cre-mediated loss of
Bhlhb5 in DRG neurons does not result in skin lesions (Fig-
ure 5B). Rather, our studies suggest that the heightened itch in
Bhlhb5 mutant mice is due to the loss of Bhlhb5 in inhibitory
neurons of the dorsal spinal cord (Figure 8). Thus, we propose
that peripheral neurons initiate an itch signal that is abnormally
amplified in the dorsal horn of the spinal cord, resulting in
scratching responses that culminate in the development of path-
ological skin lesions (Figure 8F). In addition, it is possible that
changes in the spinal cord of Bhlhb5 mutant mice may have an
indirect effect on the activity of primary sensory neurons. This
idea has precedent in models of neuropathic pain, where it has
recently been observed that primary nociceptors become hyper-
active as a consequence of spinal cord injury (Carlton et al.,
2009).
The behavioral assays for this study were performed primarily
with 4-week-old mice, an age where the circuits of the spinal
cord are thought to be mature (Fitzgerald, 2005). At this age,
wild-type and Bhlhb5 mutant mice show no significant differ-
ences in their responses to a number of pain assays (Figure 3),
but Bhlhb5 mutant mice show heightened responses to prurito-
gens and formalin (Figure 4), consistent with the idea that there issubsequent animals develop skin lesions following cre-mediated recombina-
tion of Bhlhb5. (Note that cre expression in these animals is not exclusive to
the spinal cord; each line also causes some recombination in other regions
of the nervous system including parts of the hindbrain.)
(E) Conditional loss of Bhlhb5 in the Pax2-cre domain, but not the Tlx3-cre
domain, results in significantly elevated scratching responses following the
intradermal injection of compound 48/80 into the nape of the neck relative to
littermate controls lacking cre alleles. Data are presented as mean ± SEM,
and (*) indicates significant difference relative to controls (p < 0.05, t test).
(F) Model: disinhibition gives rise to abnormally heightened itch in Bhlhb5/
mice. In wild-type mice, pruritic agents at the skin’s surface activate a subset
of itch-mediating DRG neurons that project from the periphery to the dorsal
horn of the spinal cord. This pruritic information is modulated by excitatory
(blue) and inhibitory (red) neurons in the dorsal horn before being relayed to
the brain and being experienced as the sensation of normal itch. In Bhlhb5
mutant mice, there is a loss of inhibitory neurons in the dorsal horn. Thus,
reduced inhibitory synaptic input in the dorsal horn (disinhibition) results in
a greater itch signal that is conveyed to the brain, resulting in abnormally
heightened itch that may ultimately give rise to pathological skin lesions.
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Bhlhb5mutant mice. In contrast, a few weeks later—subsequent
to the development of skin lesions—Bhlhb5 mutant mice
show somewhat higher pain thresholds than wild-type con-
trols (Figures S3E–S3G). One possibility is that the increased
pain threshold in older mice is a secondary consequence of
the skin lesions. Though the scratching behavior is likely due to
itch, the ensuing tissue damage might also cause pain, and
either of these sensations could be a confounding factor in
behavioral assays for nociception. It remains possible, however,
that Bhlhb5 mutant mice develop reduced sensitivity to pain
with a latent onset. Future studies will be required to clarify this
issue.
Several recent studies have revealed that one of the central
mechanisms underlying the development of pain hypersensi-
tivity is reduced inhibitory synaptic input in the dorsal horn of
the spinal cord. For instance, pharmacological blockade of either
GABA or glycine receptors enhances the electrophysiological
responses to the activation of primary nociceptors (Baba et al.,
2003; Torsney and MacDermott, 2006). Moreover, a reduction
of inhibitory synaptic transmission has been shown to play
a role in pain sensitization through a variety of mechanisms,
including a loss of GABAergic interneurons in the dorsal horn
(Moore et al., 2002; Scholz et al., 2005) and the inhibition of
glycine receptor function (Zeilhofer, 2005). However, while mul-
tiple studies have shown that pain is aggravated by reduced
synaptic inhibition in the dorsal spinal cord, whether analogous
mechanisms regulate pruritis was unknown. Our study clarifies
this issue by uncovering a role for disinhibition in the regulation
of itch.
The only itch-specific neurons in the spinal cord identified at
a molecular level to date are those that express GRPR (Sun
et al., 2009). Beyond these, other neurons within itch circuits of
the dorsal horn remain completely unknown, underscoring
a fundamental gap in current knowledge with regard to pruritic
circuitry. Our study begins to bridge this gap by providing
evidence that a distinct population of inhibitory interneurons
within the dorsal horn functions to inhibit itch, and that loss of
these neurons results in persistent itch that gives rise to patho-
logical lesions. Thus, Bhlhb5 inhibitory neurons may represent
the first inhibitory component of puritic circuits to be identified
genetically. In addition, theBhlhb5-cremouse provides a genetic
marker with which to identify this population of cells. Using this
molecular handle, it should be possible to define the molecular,
electrophysiological, and morphological characteristics of these
neurons and characterize exactly how, where, and when they
regulate itch. We speculate that chronic severe itch in some
patients may result from a similar kind of disinihibiton to that
described here, rather than from the increased activation of
pruritoceptors as is commonly assumed. If so, the inhibitory
neurons identified in this study may ultimately provide a cellular
target for the development of therapies for chronic itch.EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for details on the generation of
Bhlhb5-directed antibodies, animal husbandry, colony management, immu-896 Neuron 65, 886–898, March 25, 2010 ª2010 Elsevier Inc.nohistochemistry, Xgal staining, and the generation of Bhlhb5 null, Bhlhb5
conditional knockout, and Bhlhb5-cre knockin mice.
Behavioral Assays
Where appropriate, mice were habituated for 20 min/day over several days.
For observational studies, habituated mice were placed individually in a clear
cage and videotaped for 20 min and scored for their behavior. To assess
mechanical sensitivity, calibrated von Frey fibers were applied to the plantar
surface of the hindpaws of mice. The smallest monofilament that evoked
paw-withdrawal responses on five out of ten trials was taken as the mechan-
ical threshold. To determine thermal pain threshold, mice were placed on
a 55C hot plate and the response latency to paw licking or jumping was
recorded. For tests of acute nociception, capsaicin (2.5 mg) or mustard oil
(0.75%) was injected subcutaneously into the plantar surface of the hindpaw
in a 20 ml volume. For the formalin tests, the mice received 25 ml intraplantar
injection of 5% formalin, and the lickings of the injected paw were recorded
in 5 min intervals for 1 hr for the subsequent hour. To test for mechanical
hypersensitivity, the paw withdrawal threshold was determined 2 hr after the
intraplantar injection of 2% carrageenan into the hindpaw in a 20 ml volume.
To test for pruritic responses, each of the pruritic compounds were injected
intradermally into the nape of the neck in a 50 ml volume, and the bouts of
scratching that occurred over the subsequent hour were quantified.
The pruritic compounds used were histamine (1 mmol), aMe5HT (30 mg),
SLIGRL-NH2 (100 nmol), compound 48/80 (100 mg) formalin (5%), and chloro-
quine (200 mg). To investigate the involvement of sensory feedback, Bhlhb5/
mice that had pre-existing skin lesions in the perineum (or wild-type litter-
mates) were injected with 200 ml of 0.3% lidocaine (or PBS, as a control)
subcutaneously into the perineum. Ten minutes later, the scratching and
licking behavior directed toward the perineum was assessed every 10 s for
a total of 10 min.
Quantification of Neurons
For neuronal quantification experiments, three to five pairs of P0 littermates
were analyzed. Ten matched lumbar sections per animal were used for quan-
tification, spanning 2000 mm. Cell counts in various regions of the spinal cord
were conducted using the cell count function of Metamorph (Molecular
Devices). Metamorph cell scoring parameters were validated by manual
counts and were kept constant across all conditions. To quantify apoptotic
neurons, mice were analyzed in a similar fashion, and cleaved caspase-3-posi-
tive cells in the dorsal horn were counted manually. All counts were conducted
blind to genotype.
SUPPLEMENTAL INFORMATION
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